Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-11

Clinical Trial Update: Study of Trifarotene Cream to Assess Risk of a Trophic Acne Scar Formation [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating trifarotene cream for safety in acne vulgaris, specifically assessing the risk of trophic acne scar formation; results posted 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trifarotene Cream (trifarotene)

Snippet

Sponsor: Galderma R&D | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED | Results posted: 2024-06-11